Scarica l'app Stockscreener
0.522
9.77%
-0.0565
Dopo l'orario di chiusura:
.51
-0.012
-2.30%
Ensysce Biosciences Inc Borsa (ENSC) Ultime notizie
Ensysce Biosciences Presenting at Upcoming Meetings - GuruFocus.com
Perceptive Advisors LLC's Strategic Acquisition of Ensysce Biosc - GuruFocus.com
3 Penny Stocks to Watch Now, 10/24/24 - TipRanks
Regeneron Pharmaceuticals (REGN) Stock Drops Amid Market Volatility - GuruFocus.com
Advaxis (ADXS) Sees 112.96% Surge Amid Market Volatility - GuruFocus.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Ensysce Biosciences adjusts quorum requirement for stockholder meetings - Investing.com India
Ensysce Biosciences adjusts quorum requirement for stockholder meetings By Investing.com - Investing.com South Africa
When Will Ensysce Biosciences, Inc. (NASDAQ:ENSC) Breakeven? - Simply Wall St
Ensysce Biosciences Inc (ENSC) presents a great opportunity, but the stock is slightly undervalued - US Post News
ENSC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Closing Figures: Ensysce Biosciences Inc (ENSC)’s Negative Finish at 0.17, Down -4.39 - The Dwinnex
Anchoring Your Portfolio: Is ENSC Stock a Safe Harbor? - The InvestChronicle
Ensysce Biosciences Inc (ENSC) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Market Momentum: Ensysce Biosciences Inc (ENSC) Registers a -14.87 Decrease, Closing at 0.19 - The Dwinnex
ENSC stock touches 52-week low at $0.19 amid market challenges By Investing.com - Investing.com South Africa
ENSC stock touches 52-week low at $0.19 amid market challenges - Investing.com
Ensysce Biosciences Announces Leadership Team’s Participation in the Annual Pain Therapeutics Summit - StockTitan
Ensysce meets Nasdaq requirements, advances pain treatment - Investing.com
Ensysce meets Nasdaq requirements, advances pain treatment By Investing.com - Investing.com Canada
Ensysce Biosciences responds to recent shareholder inquiries - TipRanks
Ensysce Biosciences Provides Shareholder Update, Responds to Recent Shareholder Inquiries - AccessWire
ENSC stock touches 52-week low at $0.23 amid market challenges - Investing.com Canada
ENSC Stock Update: Ensysce Biosciences Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
Ratio Analysis: Unpacking Ensysce Biosciences Inc (ENSC)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Ensysce Biosciences faces Nasdaq delisting over noncompliance By Investing.com - Investing.com Australia
Ensysce Biosciences faces Nasdaq delisting over noncompliance - Investing.com
Ensysce Biosciences (NASDAQ:ENSC) Stock Quotes, Forecast and News Summary - Benzinga
Ensysce Biosciences Receives Notice from Nasdaq - AccessWire
Ensysce Biosciences, Inc. (NASDAQ:ENSC) Short Interest Update - Defense World
ENSC stock touches 52-week low at $0.31 amid market challenges - Investing.com Canada
Ensysce Biosciences submits Phase 3 study protocol for pain treatment - Investing.com
Ensysce Biosciences submits Phase 3 study protocol for pain treatment By Investing.com - Investing.com Australia
Ensysce Biosciences Submits Phase 3 Protocol to the FDA - AccessWire
Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024 - AccessWire
Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Increases By 3,885.0% - Defense World
ENSC stock touches 52-week low at $0.34 amid market challenges - Investing.com India
Is Ensysce Biosciences Inc (ENSC) worth investing in despite its undervalued state? - US Post News
Market Insight: Ensysce Biosciences Inc (ENSC)’s Notable Drop, Closing at 0.40 - The Dwinnex
Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On? - MSN
ENSC stock touches 52-week low at $0.36 amid market challenges - Investing.com India
Balance Sheet Breakdown: Ensysce Biosciences Inc (ENSC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Ensysce Biosciences announces $5M concurrent offering, shares fall - MSN
Ensysce Biosciences secures $5 million from stock sales - Investing.com
SEC Form 424B5 filed by Ensysce Biosciences Inc. - Quantisnow
ENSCEnsysce Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):